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Energization-dependent endogenous activation of proton conductance
in skeletal muscle mitochondria
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*MRC Dunn Human Nutrition Unit, Hills Road, Cambridge CB2 0XY, U.K., and †Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, Box 289,
Addenbrooke’s Hospital, Cambridge CB2 0QQ, U.K.
Leak of protons into the mitochondrial matrix during substrate
oxidation partially uncouples electron transport from phosphoryl-
ation of ADP, but the functions and source of basal and inducible
proton leak in vivo remain controversial. In the present study
we describe an endogenous activation of proton conductance
in mitochondria isolated from rat and mouse skeletal muscle
following addition of respiratory substrate. This endogenous ac-
tivation increased with time, required a high membrane potential
and was diminished by high concentrations of serum albumin.
Inhibition of this endogenous activation by GDP [classically
considered specific for UCPs (uncoupling proteins)], carboxy-
atractylate and bongkrekate (considered specific for the adenine
nucleotide translocase) was examined in skeletal muscle mito-
chondria from wild-type and Ucp3-knockout mice. Proton con-
ductance through endogenously activated UCP3 was calculated as
the difference in leak between mitochondria from wild-type and
Ucp3-knockout mice, and was found to be inhibited by carboxy-
atractylate and bongkrekate, but not GDP. Proton conductance in
mitochondria from Ucp3-knockout mice was strongly inhibited
by carboxyatractylate, bongkrekate and partially by GDP. We
conclude the following: (i) at high protonmotive force, an
endogenously generated activator stimulates proton conductance
catalysed partly by UCP3 and partly by the adenine nucleotide
translocase; (ii) GDP is not a specific inhibitor of UCP3, but
also inhibits proton translocation by the adenine nucleotide
translocase; and (iii) the inhibition of UCP3 by carboxyatractylate
and bongkrekate is likely to be indirect, acting through the adenine
nucleotide translocase.
Key words: adenine nucleotide translocase, carboxyatractylate,
GDP, proton leak, uncoupling protein (UCP), UCP3.
INTRODUCTION
During substrate oxidation, protons are pumped out of the mito-
chondrial matrix, creating an electrochemical proton gradient.
This protonmotive force is used to drive ATP synthesis. However,
substrate oxidation is not fully coupled to ATP synthesis;
some of the electrochemical gradient is dissipated by protons
leaking back into the matrix through natural proton conductance
pathways across the mitochondrial inner membrane [1,2]. Mito-
chondrial proton leak may cause up to 25% of the resting
metabolic rate [3,4] and may still be significant when ATP
turnover is high [5]. The prominence of mitochondrial proton leak
suggests that it is physiologically important, and several roles have
been suggested [4], including protection against mitochondrial
free radical production [6] and regulation of insulin secretion in
pancreatic β-cells [7].
Proton leak occurs through several pathways, some basal and
some inducible. Membranes are themselves intrinsically leaky
to protons [8] but proteins embedded in a bilayer can greatly
increase permeability [4,9,10]. Half to two-thirds of the basal
mitochondrial proton conductance is dependent upon the most
abundant carrier protein in the mitochondrial inner membrane,
the ANT (adenine nucleotide translocase) [11]. ANT-dependent
basal proton conductance occurs even if the carrier is inhibited
by carboxyatractylate, showing that this leak pathway does not
require normal carrier function [11].
Unlike basal proton conductance, specific activators and inhib-
itors affect inducible proton conductance. Inducible conductance
can be catalysed by ANT in the presence of fatty acids [12,13],
AMP [14] or the lipid peroxidation product hydroxynonenal [15].
This pathway is inhibited by carboxyatractylate, bongkrekate and
by the ANT substrates, ATP or ADP. It is not known to be
sensitive to other nucleotides. Other mitochondrial carriers, such
as the glutamate [16] and phosphate carriers [17], will catalyse
proton conductance in the presence of fatty acids. Specific UCPs
(uncoupling proteins) also catalyse inducible proton conductance
[18–21]. The best understood is UCP1, found primarily in brown
adipose tissue and specialized for adaptive thermogenesis. Proton
conductance through UCP1 is activated by fatty acids [22],
superoxide [23], derivatives such as hydroxynonenal [15,24] and
hydroxynonenal analogues (such as retinoic acid [25]). UCP2,
found in a variety of tissues [26], and UCP3, found primarily
in skeletal muscle [27,28], can be activated by fatty acids
[29,30], superoxide [23] and hydroxynonenal and its analogues
[15].
A striking aspect of the UCPs is the inhibition of their proton
conductance by a broad range of purine nucleotides. Unlike the
proton conductance of the adenine nucleotide carrier, UCPs are
strongly inhibited not only by ATP and ADP, but also by GTP and
GDP [14]. This difference in specificity has led to widespread use
of GDP as a diagnostic inhibitor of UCP function in vitro (e.g.
[31–34]), particularly in systems that lack a UCP-ablated control
[35–38].
In the present study we report an endogenous increase in the
proton conductance of skeletal muscle mitochondria incubated at
a high membrane potential. It is catalysed by UCP3 and ANT.
Although it is inhibited by GDP and carboxyatractylate, these
inhibitors do not show the expected classical specificity.
Abbreviations used: ANT, adenine nucleotide translocase; TPMP, triphenylmethylphosphonium; UCP, uncoupling protein; Ucp3KO, Ucp3 knockout;
WT, wild-type.
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EXPERIMENTAL
Animals
Female Wistar rats (Charles River) and male or female mice were
housed at 21 +− 2 ◦C, 57 +− 5% humidity, 12/12 h light/dark, with
standard laboratory chow and water ad libitum, following UK
Home Office Guidelines for the Care and Use of Laboratory
Animals. Ucp3 knockout (termed Ucp3KO) [39] and wild-type
(termed WT) sibling-paired mice were used at age 12–15 weeks.
Ucp3 ablation was confirmed by PCR analysis of genomic Ucp3
and Western blot analysis in skeletal muscle mitochondria.
Mitochondria
Animals (one rat or four mice per preparation) were killed by
stunning and cervical dislocation. Mitochondria were isolated
from total hind limb skeletal muscle [15]. Mitochondria from
WT and Ucp3KO mice were prepared and assayed in parallel.
Proton-leak kinetics
Proton-leak rates across the inner membrane of isolated
mitochondria were measured as the oxygen consumption required
to pump the protons back out of the mitochondrial matrix (in the
presence of oligomycin to prevent ATP synthesis) [40]. Proton-
leak kinetics were measured as the dependence of proton-leak rate
on its driving force, protonmotive force (measured as membrane
potential in the presence of nigericin to abolish pH gradients).
Respiration rate and membrane potential were measured simul-
taneously using electrodes sensitive to oxygen or the membrane-
potential-dependent probe, TPMP+ (triphenylmethylphospho-
nium). Assay medium contained 0.35 mg/ml mitochondrial
protein, 120 mM KCl, 5 mM KH2PO4, 3 mM Hepes, 1 mM
EGTA, 0.3% (w/v) defatted BSA (unless otherwise stated), 5 µM
rotenone, 1 µg/ml oligomycin and 0.11 µM nigericin. The TPMP
electrode was calibrated with sequential additions of 0.5 µM
TPMP up to 2.5 µM and the mitochondria were energized with
4 mM succinate. Leak kinetics were measured by varying oxygen
consumption and membrane potential by sequential additions
of malonate (approx. 0.1–2.3 mM). After each run, 0.2 µM
FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone)
was added to release matrix TPMP, allowing correction for any
small baseline drift. The TPMP-binding correction was taken to
be 0.35 (µl/mg protein)−1 [41].
Measurement of ANT content by carboxyatractylate titre
Respiration was measured without oligomycin or nigericin. In
order to establish the maximum phosphorylating rate 1 mM ADP
was added, and then respiration was successively inhibited by
additions of carboxyatractylate (Calbiochem) until the resting
non-phosphorylating rate was re-established. Carboxyatractylate
binds ANT very tightly, so ANT content was interpolated as
the minimum amount of carboxyatractylate required to abolish
phosphorylating respiration [11,42].
Statistics
To test for differences in proton conductance by ANOVA or
paired Student’s t tests, we calculated respiration rates (by linear
interpolation between flanking points) at the highest membrane
potential common to all conditions on a given day. Means for
each condition (+− S.E.M.) are plotted in bar graphs, with the
mean value of the highest common potential indicated.
Figure 1 Energization-dependent proton conductance of rat skeletalmuscle
mitochondria
Proton-leak kinetics were measured in rat skeletal muscle mitochondria as described in the
Experimental section. (A) Timings of additions to the incubation chamber. Mitochondria plus
inhibitors (M) were added at t =−8 min, 4 mM succinate (S) was added at the times indicated,
then leak kinetics (LK) were measured between t = 0 and t = 3 min by titration of membrane
potential and oxygen consumption rate with malonate from 0.14 to 2.3 mM. (B) Kinetic response
of mitochondrial proton-leak rate (measured as oxygen consumption rate) to membrane potential
measured after energization with 4 mM succinate for 0.75 (open squares), 2.5 (grey squares)
or 5 min (black squares). (C) Proton-leak rate at 175 mV [solid vertical line of (B)]; the average
highest protonmotive force common to all curves generated in the experiment. (D) Comparison of
proton-leak curves generated either in a single experiment using sequential malonate additions
over 3 min (S at t =−5 min, leak kinetics measured between t = 0 and t = 3 min; squares) or
in five separate experiments each with a different concentration of malonate added at t = 0 (S at
t =−5 min; 0.14–2.3 mM malonate added at t = 0, leak kinetics measured between t = 0 and
t = 0.5 min; triangles). Values are means +− S.E.M. of duplicate experiments performed on
four (B and C) or three (D) separate preparations. One-way ANOVA was performed for (C);
P = 0.0034, with Dunnett’s multiple comparison test used post-hoc comparing other bars to
0.75 min: ∗∗P < 0.01.
RESULTS
Time-dependent endogenous activation of proton conductance in
energized rat skeletal muscle mitochondria
Preliminary investigations of proton-leak kinetics in skeletal
muscle mitochondria suggested that proton conductance
increased as the time of energization with succinate was extended.
Figure 1 characterizes this endogenous activation of proton
conductance. Mitochondria were incubated in assay medium for
a total of 8 min (Figure 1A). They were energized with succinate
for the last 0.75, 2.5 or 5 min, then proton-leak kinetics were
measured. Figure 1(B) shows that respiration driving proton
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leak increased as incubation with succinate was extended. To
allow comparison of proton-leak rates at the same driving force,
Figure 1(C) shows rates interpolated at 175 mV, the highest
common membrane potential in the experiment, indicated by the
vertical line. The proton-leak rate at 175 mV measured after 5 min
with succinate was significantly higher than that measured after
0.75 min with succinate. The total time in the assay was always
8 min, therefore endogenous proton conductance increases as the
time of incubation with succinate is extended.
Leak kinetics are measured by titrating membrane potential and
respiration rate with malonate over 3 min. If time with succinate is
important in inducing proton leak, endogenous activation should
continue during the malonate titration, causing later points to
be more uncoupled than earlier points. To test this, Figure 1(D)
shows a compilation of leak kinetics measured in five separate
experiments, each with a different concentration of malonate
added at t = 0. Time with succinate was the same for all titration
points (broken line). This was overlaid on the leak kinetics
measured during one standard experiment using five sequential
additions of malonate (as in Figure 1B), where time with succinate
differed between titration points (solid line). There was no dif-
ference in leak kinetics between the two protocols. Therefore
energization-dependent uncoupling does not increase over the
3 min taken to measure the proton-leak kinetics suggesting no
further increases after the first malonate addition.
Malonate attenuates the energization-dependent increase in
proton conductance by lowering membrane potential in rat skeletal
muscle mitochondria
To test the ability of malonate to blunt energization-dependent,
endogenous activation of proton leak, 430 µM malonate was
added immediately before succinate. At t = 0, after incubation
with succinate for 1.5 min, this concentration of malonate lowered
the membrane potential by approx. 12 mV (X in Figure 2). Suc-
cinate was added 1.5 min or 5 min before the leak titration, which
was completed as normal with sequential additions of malonate
(Figure 2B). Figure 2(A) shows the control without malonate pre-
addition.
To allow comparison of proton-leak rates at the same driving
force, Figure 2(C) shows the time-dependent increases in rates
with succinate, interpolated at the highest common membrane
potential, 169 mV. The leak induced between 1.5 and 5 min
was significantly lower when 430 µM malonate was present,
therefore malonate does indeed attenuate the energization-
dependent increase in proton conductance.
Pre-addition of malonate could inhibit energization-dependent
induced leak directly, or by lowering protonmotive force, or by
oxidizing the electron transport chain. To test these possibilities,
the experiment in Figure 2(C) was repeated using the complex
IV inhibitor, KCN, at a concentration that lowers the membrane
potential to the same extent as 430 µM malonate. Leak kinetics
were measured in the absence (Figure 2D) or presence (Figure 2E)
of 43 µM KCN. At the highest common membrane potential,
proton conductance induced by succinate between 1.5 and 5 min
in the presence of 43 µM KCN (Figure 2F) was significantly
lower than in its absence. Unlike malonate, KCN reduces electron
transport chain intermediates. The two inhibitors decreased
energization-dependent proton conductance to a similar extent,
suggesting that it is high membrane potential, not a particular
redox state, that is required for energization-dependent induction
of proton conductance.
The increase in proton conductance between 1.5 and 5 min
incubation with succinate was also measured at intermediate
concentrations of pre-added malonate or KCN. This produced
Figure 2 Sensitivity of energization-dependent proton conductance in rat
skeletal muscle mitochondria to membrane potential
(A–C) Effect of malonate. (D–F) Effect of KCN. (A, B, D and E) Proton-leak kinetics. Succinate
at 4 mM was added at t =−1.5 min (open symbols) or t =−5 min (closed symbols) (see
Figure 1A). Proton-leak kinetics were measured between t = 0 and t = 3 min after no treatment
(A and D) or addition of 430 µM malonate (B) or 43 µM KCN (E) immediately prior to addition
of succinate. (C and F) Inhibition of energization-dependent proton leak by malonate and KCN.
The increase in proton conductance at t = 0 caused by incubation with succinate between
−5.0 min and −1.5 min was interpolated at the highest common membrane potential, 169 mV
[solid vertical line in (A and B)] in (C) and 170 mV [solid vertical line in (D and E)] in (F). ‘X’
indicates the drop in membrane potential measured at t = 0 caused by addition of malonate or
KCN prior to addition of succinate at t =−1.5 min. (G) Effect of this drop in membrane potential
on energization-dependent increase in proton conductance. The increases in proton-leak rate
from (C) and additional experiments (results not shown) using 140 µM and 290 µM malonate
(circles), and from (F) and additional experiments (results not shown) using 14 µM and 29 µM
KCN (triangles) are plotted against the drop (‘X’) in membrane potential at t = 0 after succinate
addition at t =−1.5 min. Values are means +− S.E.M. of five (A–C) or six (D–F) experiments
each performed in duplicate. ∗P < 0.03, significantly different from no addition as measured by
paired Student’s t test. Lines in (G) are linear regressions.
intermediate drops in membrane potential at t = 0 following
1.5 min with succinate (equivalent to X in Figure 2B and
Figure 2E). To characterize the ability of decreased membrane
potential to blunt energization-dependent induction of proton
conductance, Figure 2(G) shows the increase in leak rate
(e.g. Figures 2C and 2F) plotted against the drop (X) in
membrane potential caused by different concentrations of pre-
added malonate or KCN. There was a linear decrease in activation
as membrane potential during the activatory period was decreased.
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Figure 3 Modulation of energization-dependent leak in rat skeletal muscle mitochondria by BSA, phenylbutylnitrone and palmitate
(A–C) Effect of 1 % BSA. (D–F) Effect of phenylbutylnitrone (PBN). (G–I) Effect of palmitate. (A, B, D, E, G and H) Proton-leak kinetics. Succinate at 4 mM was added at t =−1.5 min (open
symbols) or t =−5 min (closed symbols) (see Figure 1A). Proton-leak kinetics were measured between t = 0 and t = 3 min in medium containing 0.3 % (A and D) or 1 % (w/v) BSA (B, G and
H), after no pre-treatment or pre-treatment with 0.1 mM (triangles) or 1 mM phenylbutylnitrone (diamonds) (E) or 600 µM palmitate (H). (C, F and I) Effect on energization-dependent proton leak
of 1 % BSA, phenylbutylnitrone or palmitate. The increase in proton conductance at t = 0 caused by incubation with succinate between −5 and −1.5 min was interpolated at the highest common
membrane potential, 172 mV [solid vertical line in (A, B, G and H)] in (C) and (I) and 169 mV [solid vertical line in (D and E)] in (F). Values are means +− S.E.M. of four (A–C), three (D–F) or three
(G–I) experiments, each performed in duplicate. ∗P < 0.01, significantly different from 0.3 % BSA as measured by paired Student’s t test.
The linear regressions for malonate and KCN overlap, suggesting
a conserved mechanism of inhibition through the lowering of
membrane potential. Extrapolation to zero effect suggests that a
decrease of 20 mV is sufficient to prevent activation of proton
conductance.
Therefore the endogenous energization-dependent activation
of proton conductance following addition of succinate requires
a high membrane potential. Activation increases over 5 min
with succinate but during subsequent titrations with malonate
the membrane potential falls by more than 20 mV and further
activation is prevented.
What is the activator of the energization-dependent increase in
proton conductance in rat skeletal muscle mitochondria?
BSA removes putative endogenous activators, including fatty
acids [43] and reactive oxygen species [6] and their derivatives
such as reactive alkenals [15]. To test whether these endogenous
activators were involved in the observed energization-dependent
proton leak, the concentration of BSA was increased in the
standard assay medium from 0.3% to 1% (w/v) (Figures 3A–
3C). Proton-leak kinetics were measured after energization with
succinate for 1.5 or 5 min in the presence of 0.3% (Figure 3A)
or 1% (Figure 3B) BSA. At 172 mV, leak induced between 1.5
and 5 min in assay medium containing 1%BSA was significantly
lower than in 0.3% BSA (Figure 3C), showing that BSA blunts
energization-dependent activation of proton conductance and
suggesting that an endogenous activator that is quenched by BSA
mediates the induced leak.
To test the possibility that the increase in energization-
dependent leak is due to lipid peroxidation products, phenylbutyl-
nitrone, a chain-breaking spin trap that quenches carbon-centred
radical intermediates, was pre-added to the assay medium at
concentrations known to inhibit lipid peroxidation [44]. Proton-
leak kinetics were measured after energization with succinate for
1.5 or 5 min in the absence (Figure 3D) or presence (Figure 3E)
of phenylbutylnitrone. At 169 mV, there was no significant
effect of phenylbutylnitrone on leak induced between 1.5 and
5 min (Figure 3F), suggesting that pathways that generate lipid
peroxidation products through a carbon-centred radical sensitive
to phenylbutylnitrone are not involved in the energization-
dependent uncoupling. However, other reactive oxygen species-
related activators remain candidates.
Energization might either generate a pool of activator, or allow
activation of uncoupling using a pre-existing activator pool (e.g.
through an energization-dependent change in conformation of
an UCP). To distinguish between these alternatives, we tested
the effect of pre-addition of fatty acids in medium containing
1% BSA. Proton-leak kinetics were measured in 1% BSA in the
absence (Figure 3G) or presence (Figure 3H) of 600 µM palmitate
after energization with succinate for 1.5 or 5 min. Figure 3(I)
replicates the observation in Figure 3(C) that 1% BSA alone
prevented time-dependent activation. Pre-addition of palmitate
did not overcome the inhibitory effect of 1% BSA, showing that
time-dependent activation did not occur by potential-dependent
changes in protein conformation that then allowed activation by
a pre-existing pool of fatty acids. Fatty acids remain, however,
one candidate for the endogenously generated activator, since
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Figure 4 Inhibition of proton conductance in rat skeletal muscle
mitochondria by GDP and carboxyatractylate
(A) Proton-leak kinetics measured between t = 0 and t = 3 min following addition of inhibitors
(where present) and mitochondria at t =−5.5 min. Succinate at 4 mM was added at
t =−2.5 min (see Figure 1A) in the presence of no additions (squares), 500 µM GDP
(triangles), 2.5 µM carboxyatractylate (diamonds) or GDP and carboxyatractylate (circles).
(B) Absolute respiration rate at 180 mV [solid vertical line in (A)] in each condition. Values
are means +− S.E.M. of 15 experiments, each performed in duplicate. One-way ANOVA was
performed for (B); P = 0.0001, with Dunnett’s multiple comparison test used post-hoc
comparing other bars to control: ∗∗P < 0.01.
proton-leak kinetics in the presence of palmitate (Figure 3H) were
the same after 1.5 min incubation with succinate as those seen in
0.3% BSA after 5 min with succinate (Figure 3A).
These experiments are consistent with at least three different
interpretations. The endogenous activator may be (i) fatty acids,
(ii) some other molecule, generated during 5 min incubation at
high membrane potential, or (iii) some molecule (e.g. hydroxy-
nonenal) that is already present in the mitochondria before addi-
tion of succinate, but requires the membrane potential to be high
for several minutes to allow the interaction that causes uncoupling.
Which proteins catalyse the energization-dependent increase in
proton conductance in rat skeletal muscle mitochondria?
Uncoupling through the ANT is inhibited by carboxyatractylate
[13], whereas uncoupling through UCPs is classically inhibited
by GDP [14,45]. Proton-leak kinetics were measured after
energization with succinate for 2.5 min in the absence and
presence of carboxyatractylate and GDP to determine whether
ANT and UCP3 were involved (Figure 4A). Figure 4(B)
shows that at the highest common membrane potential, 180 mV,
GDP and carboxyatractylate significantly inhibited proton
conductance separately and in combination. The extent of the
carboxyatractylate inhibition of proton conductance suggests that
the majority is attributable to ANT. As observed previously [15],
inhibition of proton conductance by GDP and carboxyatractylate
was non-additive; characterization of the relative contributions of
ANT and UCP3 therefore required further experiments.
UCP3 and ANT each catalyse part of the energization-
dependent increase in proton conductance in mouse
skeletal muscle mitochondria
The contribution of UCP3 to energization-dependent proton
conductance was assessed using skeletal muscle mitochondria
prepared from WT and Ucp3KO mice. Proton-leak kinetics were
Figure 5 Contribution of UCP3 and ANT to energization-dependent leak in
mouse skeletal muscle mitochondria
(A andB) Proton-leak kinetics. (A) Mitochondria from WT mice. (B) Mitochondria from Ucp3KO
mice. Succinate at 4 mM was added at t =−1.5 min (open symbols) or t =−5 min (closed
symbols) (see Figure 1A). (C) Proton leak due to UCP3 measured at 169 mV [solid vertical
line in (A and B)] as (A) minus (B). Values are means +− S.E.M. of seven experiments, each
performed in duplicate. ∗∗P < 0.01, significantly different by paired Student’s t test (5 min
succinate addition compared with 1.5 min).
measured after energization with succinate for 1.5 or 5 min.
Figure 5(A) shows that skeletal muscle mitochondria from WT
mice showed a similar time-dependent increase in proton leak
after addition of succinate to mitochondria from rat (Figure 1B).
Figure 5(B) shows the same experiment performed using skeletal
muscle mitochondria from Ucp3KO mice. There was still a
difference between the curves, but it was smaller than in WT.
The difference is quantified in Figure 5(C), which shows proton
leak through UCP3, expressed as the difference between rates
in skeletal muscle mitochondria from WT and Ucp3KO mice at
169 mV. UCP3-associated proton conductance was significantly
greater after incubation with succinate for 5 min than for 1.5 min.
In the presence of UCP3, the increase in respiration rate between
1.5 and 5 min was 75 nmol of O/min per mg of protein whereas
in the absence of UCP3 it was 62 nmol of O/min per mg of
protein. Thus approx. 17% of the energization-dependent proton
leak induced between 1.5 and 5 min incubation with succinate
requires the presence of UCP3.
The contribution of ANT to the proton conductance observed
after 5 min incubation with succinate was assessed as the carboxy-
atractylate-sensitive effect in skeletal muscle mitochondria from
Ucp3KO mice. Figure 6(B) shows that carboxyatractylate sub-
stantially inhibited energization-dependent proton conductance
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Figure 6 Inhibition of proton conductance in skeletal muscle mitochondria
from Ucp3WT and Ucp3KO mice by GDP and carboxyatractylate
(A andB) Proton-leak kinetics. (A) Mitochondria from WT mice. (B) Mitochondria from Ucp3KO
mice. Succinate at 4 mM was added at t =−5 min (see Figure 1A). Proton-leak kinetics were
measured after 5 min incubation with 4 mM succinate in the absence (closed symbols) or
presence of 500 µM GDP (dark grey symbols), 2.5 µM carboxyatractylate (light grey symbols)
or GDP and carboxyatractylate (open symbols). (C) Proton leak due to UCP3 measured at 161 mV
[solid vertical line in (A and B)] as (A) minus (B). (D) Proton leak not due to UCP3 measured
at 161 mV, data from (B). (E) Carboxyatractylate titration of ANT content in mitochondria from
WT mice (squares) and Ucp3KO mice (triangles). Values are means +− S.E.M. of ten (A–D) and
four (E) experiments, each performed in duplicate. One-way ANOVA was performed for (C)
and (D); P = 0.0001, with Dunnett’s multiple comparison test used post-hoc comparing other
bars to control: ∗P < 0.05; ∗∗P<0.01.
in the absence of UCP3. The effect is quantified in Figure 6(D),
which shows UCP3-independent leak at 161 mV. Carboxy-
atractylate lowered the rate from 90 to 30 nmol of O/min per
mg of protein, equivalent to approx. 50–55% of the total effect
in mitochondria from WT mice in Figure 6(A). Together, these
results show that the energization-dependent proton conductance
in mouse skeletal muscle mitochondria is catalysed approx. 15–
20% by UCP3, 50–55% by ANT and 25–30% by other pathways
not sensitive to GDP or carboxyatractylate (e.g. the dicarboxylate
carrier).
Specificity and lack of additivity of inhibition by GDP and
carboxyatractylate in mouse skeletal muscle mitochondria
To investigate the lack of additivity between the inhibitors GDP
and carboxyatractylate in rat skeletal muscle (Figure 4), and also
seen in other studies [15], inhibition was measured in skeletal
muscle mitochondria from WT and Ucp3KO mice. The same
lack of additivity was seen in skeletal muscle mitochondria
from WT mice (Figure 6A) as in rat: GDP partially inhibited
proton conductance in the absence of carboxyatractylate but
caused no further inhibition in the presence of carboxyatractylate.
Figure 6(B) shows the same effect in mitochondria from Ucp3KO
mice.
Figures 6(C) and 6(D) dissect out the effects of the inhib-
itors. Figure 6(C) represents the contribution of UCP3 (Figure 6A
minus 6B) at the highest common membrane potential, 161 mV,
after 5 min incubation with succinate. Surprisingly (since GDP
is the classical inhibitor of UCPs), the proton conductance
through UCP3 under these conditions was insensitive to GDP.
More surprisingly (since carboxyatractylate is thought to be a
highly specific inhibitor of ANT), it was almost fully sensitive to
carboxyatractylate. This sensitivity of UCP3 to carboxyatractylate
partially explains the lack of additivity of the two inhibitors: once
UCP3 is inhibited by carboxyatractylate, any inhibition by GDP
would have no further effect.
Figure 6(D) represents the contribution of ANT and other
pathways (results from Figure 6B). The energization-dependent
proton conductance of mitochondria from Ucp3KO mice was
significantly lower in the presence of GDP, indicating that an
endogenously activated pathway other than UCP3 was inhibited
by GDP. Since this conductance was also strongly inhibited by
carboxyatractylate, it was catalysed by ANT. This experiment
shows that GDP is not specific for UCPs, but can also inhibit
proton conductance through other pathways, specifically ANT. It
completes the explanation of the lack of additivity of GDP and
carboxyatractylate: once ANT is inhibited by carboxyatractylate,
inhibition by GDP would have no further effect. Together, these
results highlight potential promiscuity of the inhibitors GDP and
carboxyatractylate: neither is specific for its classical target in our
experiments.
A possible alternative explanation of the sensitivity of
mitochondria from Ucp3KO mice to GDP is that the Ucp3KO
targeting vector upregulates Ucp2 expression, due to proximity of
the Ucp2 and Ucp3 genes [46], and it is this UCP2 that is inhibited
by GDP. We detected Ucp2 transcript in total hind limb skeletal
muscle using real-time PCR, but at levels 30 times lower than in
spleen or lung, with no significant difference between WT and
Ucp3KO (results not shown). UCP2 was undetectable by Western
blot analysis using skeletal muscle mitochondria (20 µg of
protein) from either WT or Ucp3KO mice. The antibody can detect
125 pg of affinity-purified recombinant UCP2, so UCP2 content
is below 6 ng/mg of mitochondrial protein, less than 5% of the
UCP3 content of 140 ng/mg of protein in mouse skeletal muscle
mitochondria [47]. UCP1 is not expressed in skeletal muscle of
WT or Ucp3KO mice [48]. Therefore the putative presence
of UCP1 or UCP2 does not explain the sensitivity of proton
conductance in skeletal muscle mitochondria from Ucp3KO mice
to GDP.
A possible alternative explanation of the decreased effect of
carboxyatractylate in mitochondria from Ucp3KO mice is that
ablation of UCP3 somehow decreased ANT content. We tested
this possibility by titrating ANT activity with carboxyatractylate
in skeletal muscle mitochondria from WT and Ucp3KO mice.
UCP3 (4 pmol/mg of mitochondrial protein [47]) is approx. 0.2%
as abundant as ANT (2 nmol/mg of mitochondrial protein [11]),
so any sequestering of carboxyatractylate by UCP3 would be
negligible. ANT content was not significantly different (WT,
1.52 nmol/mg of protein and Ucp3KO, 1.56 nmol/mg of protein;
Figure 6E), eliminating this explanation.
Inhibition of UCP3 by carboxyatractylate could be direct or
through ANT. To examine this, we tested the effects of an
alternative ANT inhibitor, bongkrekate. Unlike carboxyatractyl-
ate, which binds to the C conformation of the carrier, bongkrekate
binds to the M conformation [49]. BSA was omitted from
the assay medium because it binds bongkrekate. Proton-leak
kinetics were measured in skeletal muscle mitochondria isolated
from WT (Figure 7A) and Ucp3KO (Figure 7B) mice after
energization with succinate for 5 min in the absence or presence
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Figure 7 Inhibition of proton conductance in Ucp3WT and Ucp3KO mouse
skeletal muscle mitochondria by carboxyatractylate and bongkrekate
(A andB) Proton-leak kinetics. (A) Mitochondria from WT mice. (B) Mitochondria from Ucp3KO
mice. Succinate at 4 mM was added at t =−5 min (see Figure 1A) in the absence of BSA in
the absence (closed symbols) or presence of 2.0 µM bongkrekate (dark grey) or 2.5 µM
carboxyatractylate (light grey). (C) Proton leak due to UCP3 measured at 158 mV [solid vertical
line in (A and B)] as (A) minus (B). Values are means +− S.E.M. of ten experiments, each
performed in duplicate. One-way ANOVA was performed for (C); P = 0.015, with Dunnett’s
multiple comparison test used post-hoc comparing other bars with control: ∗P < 0.05.
of bongkrekate or carboxyatractylate. Bongkrekate partially
inhibited the energization-dependent proton conductance in both
cases. Figure 7(C) shows the effects that were dependent on
UCP3 (Figure 7A minus 7B). At the highest common membrane
potential, 158 mV, both carboxyatractylate and bongkrekate
inhibited proton conductance through UCP3. It is unlikely that
UCP3 and ANT share two different high-affinity inhibitor sites,
therefore both carboxyatractylate and bongkrekate act on the
UCP3-associated leak indirectly through primary effects on ANT.
DISCUSSION
In the present study we describe an endogenous activation of
the proton conductance of skeletal muscle mitochondria isolated
from both rats and mice that increases with time after energization.
This effect is not dependent upon redox state but requires a high
membrane potential upon succinate addition. The effect of mem-
brane potential may be to increase the production of endogenous
fatty acids or other molecules that progressively activate uncoupl-
ing, or to sensitize target proteins to the effects of generated
or pre-existing activators such as products of reactive oxygen
species. The mechanism remains unclear. Membrane potential
might change the conformation of membrane lipids to facilitate
access by phospholipases, or might change the conformations of
UCP3 and ANT to expose activator-binding sites. Mobilization of
fatty acids could explain the lack of GDP sensitivity of the UCP3-
dependent proton conductance, by analogy with UCP1, where
fatty acids functionally compete with inhibitory nucleotides [50].
Whatever the activator and mechanism, energization-dependent
uncoupling of skeletal muscle mitochondria may be important in
limiting membrane potential during rest, to limit reactive oxygen
species production [21] or prevent dielectric breakdown of the
membrane [4].
Two catalysts of energization-dependent proton conductance
were found to be UCP3 and ANT. In WT mouse skeletal muscle
mitochondria after 5 min incubation with succinate, the relative
contributions of UCP3, ANT and other pathways to proton con-
ductance were 15–20%, 50–55% and 25–30% respectively.
Since UCP3 content is only approx. 0.2% of ANT content
(see above), this result demonstrates that the specific proton flux
through UCP3 is 100–200 times greater than that through ANT.
The greater specific activity of UCP3 may allow finer control of
high membrane potential in tissues that contain this protein in
addition to ANT.
We found that GDP partially inhibited the contribution of ANT
to energization-dependent proton conductance. Khailova et al.
[51] also concluded that GDP inhibits proton translocation by
ANT, although they did not use Ucp knockout controls, which
provide our most compelling evidence that GDP can inhibit proton
conductance in the absence of UCP3. GDP and GTP bind weakly
to ANT [52], but compete poorly with ADP and ATP, so they
are not regarded as inhibitors of adenine nucleotide exchange.
However, adenine nucleotides are absent in assays of proton
conductance, which may allow guanine nucleotides to bind and
partially inhibit ANT-catalysed proton leak.
We found that carboxyatractylate inhibited the contribution
of UCP3 to proton leak. Carboxyatractylate is a high-affinity
inhibitor of ANT, and has not been shown previously to act on
other proteins. However, most other studies have not looked for
carboxyatractylate inhibition of UCP3 function. The observation
that bongkrekate also inhibits UCP3-dependent proton conduct-
ance suggests that inhibition of UCP3 is indirect, via primary
effects on ANT. It is unclear what these indirect effects might be,
but they might involve protein–protein interactions between ANT
and UCP3, or interactions through some other protein, lipid or
small molecule. More exploration of the interaction is required
to uncover the mechanism. However, the (indirect) inhibition of
UCP3 by carboxyatractylate fully explains the hitherto puzzling
lack of additivity between inhibition of proton conductance by
GDP and carboxyatractylate.
Since inhibition by GDP and carboxyatractylate is also non-
additive in mitochondria from kidney [15,44], carboxyatractylate
may also inhibit UCP2 by a similar indirect mechanism. However,
it appears that carboxyatractylate does not inhibit potato UCP [53]
or mammalian UCP1, since guanine nucleotides are still inhibitory
in the presence of carboxyatractylate in mitochondria from potato
or mammalian brown adipose tissue. Thus caution should be
shown when using sensitivity to GDP or carboxyatractylate
as diagnostic of the involvement of a UCP or ANT in
proton conductance. Observations of GDP or carboxyatractylate
sensitivity should be verified by independent assays of the
involvement of UCPs and ANT, such as sensitivity to genetic
ablation or overexpression.
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